Opus Genetics
IRD
17 hedge funds and large institutions have $470K invested in Opus Genetics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
11% more capital invested
Capital invested by funds: $422K → $470K (+$48K)
6% more funds holding
Funds holding: 16 → 17 (+1)
0.25% more ownership
Funds ownership: 1.29% → 1.54% (+0.25%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$73.9K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.83K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.33K |
| 4 |
SMFS
Squar Milner Financial Services
Irvine,
California
|
+$30 |
| 5 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$1K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$53 |
| 3 |
Morgan Stanley
New York
|
-$23 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $283K | +$73.9K | +9,807 | +36% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $106K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $50K | – | – | – |
|
4
BlackRock
New York
| $17K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $12K | +$1.33K | +176 | +12% |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$2.83K | +375 | New |
|
|
APA
7
American Portfolios Advisors
Holbrook,
New York
| $15 | – | – | – |
|
|
8
Victory Capital Management
San Antonio,
Texas
| – | -$1K | -171 | Closed |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$53 | -7 | -37% |
|
|
10
Morgan Stanley
New York
| – | -$23 | -3 | -8% |
|
11
Wells Fargo
San Francisco,
California
| – | +$8 | +1 | +25% |
|
|
TWA
12
TCI Wealth Advisors
Tucson,
Arizona
| – | +$15 | +2 | New |
|
|
SMFS
13
Squar Milner Financial Services
Irvine,
California
| – | +$30 | +4 | New |
|
|
FWM
14
FSA Wealth Management
Needham,
Massachusetts
| – | +$38 | +5 | New |
|
IRD Hedge Fund Activity: Q4 2019 in Review
17 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2019, worth a combined $470K — up 11% from $422K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IRD positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $73.9K. The largest seller was Victory Capital Management, exiting entirely with an estimated $1K sold.
- 17 institutional investors held Opus Genetics (IRD) as of Q4 2019, up from 16 in Q3 2019.
- Funds reported $470K of Opus Genetics stock for Q4 2019, up 11% quarter-over-quarter.
- 4 funds opened new Opus Genetics positions in Q4 2019 and 3 closed out, a net change of +1 holder.
- The largest Opus Genetics buyer in Q4 2019 was Renaissance Technologies, an estimated $73.9K added.
- The largest Opus Genetics seller in Q4 2019 was Victory Capital Management, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2019.